skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
10/15/2013
Application #:
12751517
Filing Dt:
03/31/2010
Publication #:
Pub Dt:
10/28/2010
Inventors:
Anders M. Naar, Gerhard Wagner, Joy Nishikawa, Haribabu Arthanari
Title:
HIGH THROUGHPUT SCREENS FOR SMALL-MOLECULE INHIBITORS OF THE NUCLEAR RECEPTOR-LIKE PATHWAY REGULATING MULTIDRUG RESISTANCE IN FUNGI
Assignment: 1
Reel/Frame:
024436/0022Recorded: 05/25/2010Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
05/21/2010
Exec Dt:
05/21/2010
Assignee:
55 FRUIT STREET
BOSTON, MASSACHUSETTS 02114
Correspondent:
DAVID RESNICK
100 SUMMER STREET
NIXON PEABODY LLP
BOSTON, MA 02110
Assignment: 2
Reel/Frame:
024556/0816Recorded: 06/18/2010Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
06/11/2010
Exec Dt:
06/11/2010
Assignee:
17 QUINCY STREET
CAMBRIDGE, MASSACHUSETTS 02138
Correspondent:
DAVID RESNICK
100 SUMMER STREET
NIXON PEABODY LLP
BOSTON, MA 02110
Assignment: 3
Reel/Frame:
037019/0023Recorded: 10/30/2015Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
10/29/2015
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980

Search Results as of: 05/31/2024 05:43 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT